FDA-Approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An Updated Landscape
Open accessPublished version of a preprint
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
As artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML)-enabled medical devices are increasingly used in healthcare. In this study, we collected publicly available information on AI/ML-enabled medical devices approved by the FDA in the United States, as of the latest update on 19 October 2023. We performed comprehensive analysis of a total of 691 FDA-approved artificial intelligence and machine learning (AI/ML)-enabled medical devices and offer an in-depth analysis of clearance pathways, approval timeline, regulation type, medical specialty, decision type, recall history, etc. We found a significant surge in approvals since 2018, with clear dominance of the radiology specialty in the application of machine learning tools, attributed to the abundant data from routine clinical data. The study also reveals a reliance on the 510(k)-clearance pathway, emphasizing its basis on substantial equivalence and often bypassing the need for new clinical trials. Also, it notes an underrepresentation of pediatric-focused devices and trials, suggesting an opportunity for expansion in this demographic. Moreover, the geographical limitation of clinical trials, primarily within the United States, points to a need for more globally inclusive trials to encompass diverse patient demographics. This analysis not only maps the current landscape of AI/ML-enabled medical devices but also pinpoints trends, potential gaps, and areas for future exploration, clinical trial practices, and regulatory approaches. In conclusion, our analysis sheds light on the current state of FDA-approved AI/ML-enabled medical devices and prevailing trends, contributing to a wider comprehension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fewer than 30% of AI tools have had their performance and effectiveness thoroughly scrutinized46,47.”
From Preventing unrestricted and unmonitored AI experimentation in healthcare through transparency and accountability (2025) · cites this paper as [47]
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning
Kermany, D. S., Goldbaum, M., Cai, W., Valentim, C. C. S., Liang, H., Baxter, S. L., McKeown, A., Yang, G., Wu, X., Yan, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.010 · Cited by 4,842
Artificial intelligence in radiology
Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H., & Aerts, H. J. W. L. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0016-5 · Cited by 3,803 · cited 1×
“Our analysis serves as a beacon, elucidating the current”
MethodRajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
The future landscape of large language models in medicine
Clusmann, J., Kolbinger, F. R., Muti, H. S., Carrero, Z. I., Eckardt, J.-N., Laleh, N. G., Löffler, C. M. L., Schwarzkopf, S.-C., Unger, M., Veldhuizen, G. P., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00370-1 · Cited by 1,045
A foundation model for generalizable disease detection from retinal images
Zhou, Y., Chia, M. A., Wagner, S. K., Ayhan, M. S., Williamson, D. J., Struyven, R. R., Liu, T., Xu, M., Lozano, M. G., Woodward-Court, P., et al. (2023) · Nature · doi:10.1038/s41586-023-06555-x · Cited by 1,014 · cited 1×
“Our analysis serves as a beacon, elucidating the current”
MethodShifting machine learning for healthcare from development to deployment and from models to data
Zhang, A., Xing, L., Zou, J., & Wu, J. C. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00898-y · Cited by 420 · cited 1×
“Our analysis serves as a beacon, elucidating the current”
MethodGerke, S., Babic, B., Evgeniou, T., & Cohen, I. G. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0262-2 · Cited by 359 · cited 1×
“…of logic, a collection of regulations, or a blueprint) that functions on data input (digitized information) such as lab results, images, symptoms, etc. to generate an outcome that is intended for medical applications to inform, drive, diagnose, treat, etc., as specified by the SaMD producer [12].”
BackgroundReproducibility in machine learning for health research: Still a ways to go
McDermott, M. B. A., Wang, S., Marinsek, N., Ranganath, R., Foschini, L., & Ghassemi, M. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb1655 · Cited by 273 · cited 1×
“The efficacy and robustness of these models are substantially enhanced as they are exposed to more comprehensive, diverse, and heterogeneous data, enabling the models to achieve greater accuracy and reliability in their predictive capabilities [4].”
BackgroundSolving the Explainable AI Conundrum by Bridging Clinicians’ Needs and Developers’ Goals
Bienefeld, N., Boss, J. M., Lüthy, R., Brodbeck, D., Azzati, J., Blaser, M., Willms, J., & Keller, E. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00837-4 · Cited by 159
Cited by
Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice
Khera, R., Oikonomou, E. K., Nadkarni, G. N., Morley, J. R., Wiens, J., Butte, A. J., & Topol, E. J. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.003 · Cited by 264
Machine learning in point-of-care testing: innovations, challenges, and opportunities
Han, G.-R., Goncharov, A., Eryilmaz, M., Ye, S., Palanisamy, B., Ghosh, R., Lisi, F., Rogers, E., Guzman, D., Yigci, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58527-6 · Cited by 239
A Scoping Review of Reporting Gaps in FDA-Approved AI Medical Devices
Muralidharan, V., Adewale, B. A., Huang, C. J., Nta, M. T., Ademiju, P. O., Pathmarajah, P., Hang, M. K., Adesanya, O., Abdullateef, R. O., Babatunde, A. O., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01270-x · Cited by 201
Using Machine Learning to Predict Antimicrobial Resistance―A Literature Review
Sakagianni, A., Koufopoulou, C., Feretzakis, G., Kalles, D., Verykios, V. S., Myrianthefs, P., & Fildisis, G. (2023) · Antibiotics · doi:10.3390/antibiotics12030452 · Cited by 176
Ali, T., Ahmed, S., & Aslam, M. (2023) · Antibiotics · doi:10.3390/antibiotics12030523 · Cited by 170
Miao, J., Thongprayoon, C., Suppadungsuk, S., Garcia Valencia, O. A., & Cheungpasitporn, W. (2024) · Medicina · doi:10.3390/medicina60030445 · Cited by 164
Artificial intelligence in cardiovascular medicine: clinical applications
Lüscher, T. F., Wenzl, F. A., D’Ascenzo, F., Friedman, P. A., & Antoniades, C. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae465 · Cited by 160
Ueda, D., Walston, S. L., Fujita, S., Fushimi, Y., Tsuboyama, T., Kamagata, K., Yamada, A., Yanagawa, M., Ito, R., Fujima, N., et al. (2024) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2024.06.002 · Cited by 174
Miao, J., Thongprayoon, C., Suppadungsuk, S., Garcia Valencia, O. A., Qureshi, F., & Cheungpasitporn, W. (2023) · Clinics and Practice · doi:10.3390/clinpract14010008 · Cited by 111
Lavidas, K., Voulgari, I., Papadakis, S., Athanassopoulos, S., Anastasiou, A., Filippidi, A., Komis, V., & Karacapilidis, N. (2024) · Information · doi:10.3390/info15060314 · Cited by 107
Enhancing medical AI with retrieval-augmented generation: A mini narrative review
Gargari, O. K., & Habibi, G. (2025) · DIGITAL HEALTH · doi:10.1177/20552076251337177 · Cited by 98
Pennisi, F., Pinto, A., Ricciardi, G. E., Signorelli, C., & Gianfredi, V. (2025) · Antibiotics · doi:10.3390/antibiotics14020134 · Cited by 145
“…agencies, including the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have begun exploring the integration of ML-based technologies into healthcare [12,13], spanning applications such as medical imaging [14], disease diagnosis [15], and patient management [16].”
Chain of Thought Utilization in Large Language Models and Application in Nephrology
Miao, J., Thongprayoon, C., Suppadungsuk, S., Krisanapan, P., Radhakrishnan, Y., & Cheungpasitporn, W. (2024) · Medicina · doi:10.3390/medicina60010148 · Cited by 101
“The integration of AI into healthcare has revolutionized various aspects including , therapeutics, and patient care [3,40–43].”
BackgroundLarge Language Model Prompting Techniques for Advancement in Clinical Medicine
Shah, K., Xu, A. Y., Sharma, Y. K., Daher, M., McDonald, C. L., Diebo, B. G., & Daniels, A. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175101 · Cited by 111
“Currently, however, there are no FDA-approved devices that utilize generative AI for clinical communication with patients, as the focus remains on devices that integrate AI for tasks like image processing and triage notification management [26].”
BackgroundHaider, A., Iqbal, S. Z., Bhatti, I. A., Alim, M., Waseem, M., Iqbal, M., & Khaneghah, A. M. (2024) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13360 · Cited by 103
Chow, J. C. L., Wong, V., & Li, K. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4010047 · Cited by 117
“The prevalence of the 510(k) clearance pathway, relying on substantial equivalence, is notable [5].”
BackgroundRoganović, J., Radenković, M., & Miličić, B. (2023) · Healthcare · doi:10.3390/healthcare11101480 · Cited by 76
Medical-informed machine learning: integrating prior knowledge into medical decision systems
Sirocchi, C., Bogliolo, A., & Montagna, S. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02582-4 · Cited by 105
“However, while some of these systems have been FDA-approved for healthcare use, they were primarily developed within radiology and cardiovascular specialities [9, 10], followed by neurology and haematology [11].”
BackgroundArtificial intelligence in digital pathology — time for a reality check
Aggarwal, A., Bharadwaj, S., Corredor, G., Pathak, T. B., Badve, S., & Madabhushi, A. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-00991-6 · Cited by 96
“This trend reflects a slower than anticipated integration of AI in digital pathology, especially considering that approvals of radiology devices typically have shorter median approval wait times (126 days) than those in other specialties (including 193 days for pathology) 66 .”
InfluentialRowan, N. J. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171672 · Cited by 94
Santamato, V., Tricase, C., Faccilongo, N., Iacoviello, M., & Marengo, A. (2024) · Applied Sciences · doi:10.3390/app142210144 · Cited by 117
“Regulators, such as the FDA in the United States, are working to balance technological innovation with patient safety and privacy [7].”
Chen, Y., Lehmann, C. U., & Malin, B. (2024) · Journal of Medical Internet Research · doi:10.2196/60258 · Cited by 110
“In the realm of medical imaging where many Food and Drug Administration (FDA)–approved AI technologies exist [74], AI, particularly deep learning, is already assuming a pivotal role in optimizing clinical workflows.”
How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations
Singh, R., Bapna, M., Diab, A. R., Ruiz, E. S., & Lotter, W. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01800-1 · Cited by 61
“Our analysis provides complementary insights to other recent reviews of FDA-authorized devices that have examined aspects such as predicate networks 12 , marketing 13 , explainability 7 , regulatory pathways 14 , and clinical validation 9,14 – 18 .”
A general framework for governing marketed AI/ML medical devices
Babic, B., Cohen, I. G., Stern, A. D., Li, Y., & Ouellet, M. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01717-9 · Cited by 78
Suleman, M. U., Mursaleen, M., Khalil, U., Saboor, A., Bilal, M., Khan, S. A., Subhani, M. A., Hussnain, M. A., Tabassum, S. N., & Tahir, M. R. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004166 · Cited by 108
“For example, a recent analysis found 691 Food and Drug Administration (FDA)-cleared AI/Machine Learning (ML) medical devices (as of late 2023), with a clear dominance of radiology applications due to the abundance of routinely acquired imaging data [ 2 ] .”
Henzler, D., Schmidt, S., Koçar, A., Herdegen, S., Lindinger, G. L., Maris, M. T., Bak, M. A. R., Willems, D. L., Tan, H. L., Lauerer, M., et al. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12664-2 · Cited by 54
“The search was restricted to original articles published in 2017 or later since following the first FDA approval of AI/ML medical technologies in the year 2016, with three approvals at the end of the year 2017 [17], there has been exponential growth in the application of AI in healthcare [18].”
Applied artificial intelligence in dentistry: emerging data modalities and modeling approaches
Fehér, B., Tussie, C., & Giannobile, W. V. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1427517 · Cited by 68
Image Analysis in Histopathology and Cytopathology: From Early Days to Current Perspectives
Mezei, T., Kolcsár, M., Joó, A., & Gurzu, S. (2024) · Journal of Imaging · doi:10.3390/jimaging10100252 · Cited by 77
“All are labeled as class IVD (In Vitro Diagnostics) devices/solutions [113,114].”
BackgroundRadiology AI and sustainability paradox: environmental, economic, and social dimensions
Koçak, B., Ponsiglione, A., Romeo, V., Ugga, L., Huisman, M., & Cuocolo, R. (2025) · Insights into Imaging · doi:10.1186/s13244-025-01962-2 · Cited by 73
Transparency of medical artificial intelligence systems
Kim, C., Gadgil, S. U., & Lee, S. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00363-w · Cited by 81
“In the USA, the FDA regulates AI-based medical tools under the Software as a Medical Device framework, which outlines key requirements for trans-parency, performance evaluation, test data quality and continuous monitoring 9,218,219 .”
Carvalho, E., Mascarenhas, M., Pinheiro, F., Correia, R., Balseiro, S., Barbosa, G., Guerra, A., Oliveira, D. A., Moura, R., Santos, A., et al. (2025) · JMIR AI · doi:10.2196/76854 · Cited by 62
“For example, the average median wait time between the date the FDA receives the complete application and the decision date is 125 days [26].”
Transforming sepsis management: AI-driven innovations in early detection and tailored therapies
Papareddy, P., Lobo, T. J., Holub, M., Bouma, H., Maca, J., Strodthoff, N., & Herwald, H. (2025) · Critical Care · doi:10.1186/s13054-025-05588-0 · Cited by 49
“Recent systematic evaluations of FDA-approved AI/ ML-enabled medical devices show that fewer than 10% are supported by prospective clinical trials, and even fewer provide transparent reporting on model performance across patient subgroups or settings [61].”
Jena, G. K., Patra, C. N., Jammula, S., Rana, R., & Chand, S. (2024) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0016 · Cited by 95
Value of Artificial Intelligence in Evaluating Lymph Node Metastases
Caldonazzi, N., Rizzo, P. C., Eccher, A., Girolami, I., Fanelli, G. N., Naccarato, A. G., Bonizzi, G., Fusco, N., d’Amati, G., Scarpa, A., et al. (2023) · Cancers · doi:10.3390/cancers15092491 · Cited by 48
Comeau, D. S., Bitterman, D. S., & Celi, L. A. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01443-2 · Cited by 44
Benefit-Risk Reporting for FDA-Cleared Artificial Intelligence−Enabled Medical Devices
Lin, J. C., Jain, B., Iyer, J. M., Rola, I., Srinivasan, A. R., Kang, C., Patel, H., & Parikh, R. B. (2025) · JAMA Health Forum · doi:10.1001/jamahealthforum.2025.3351 · Cited by 42
Artificial intelligence and the electrocardiogram: A modern renaissance
Palermi, S., Vecchiato, M., Ng, F. S., Attia, Z., Cho, Y., Anselmino, M., De Ferrari, G. M., Saglietto, A., Sau, A., Chiu, I.-M., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.04.036 · Cited by 42
Zhang, S., Li, Y., Liu, W., Qi, C., Wang, S., Li, J., & Chen, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1630408 · Cited by 64
Evaluating transparency in AI/ML model characteristics for FDA-reviewed medical devices
Mehta, V., Komanduri, A., Bhadouriya, R. S., Mehta, V., Johnson, M. D., Shrestha, P., Nikolov, M. C., Jain, B., Shah, N. H., & Schulman, K. A. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02052-9 · Cited by 61
González-Alday, R., García-Cuesta, E., Maojo, & Kulikowski, C. (2023) · Applied Sciences · doi:10.3390/app131910778 · Cited by 54
Exploring the Potential of Chatbots in Critical Care Nephrology
Suppadungsuk, S., Thongprayoon, C., Miao, J., Krisanapan, P., Qureshi, F., Kashani, K., & Cheungpasitporn, W. (2023) · Medicines · doi:10.3390/medicines10100058 · Cited by 37
Rehman, A. U., Lu, S., Heyat, M. B. B., Iqbal, M. S., Parveen, S., Hayat, M. A. B., Akhtar, F., Ashraf, M. A., Khan, O., Pomary, D., et al. (2025) · International Journal of Intelligent Systems · doi:10.1155/int/8546245 · Cited by 69
Innovating Personalized Nephrology Care: Exploring the Potential Utilization of ChatGPT
Miao, J., Thongprayoon, C., Suppadungsuk, S., Garcia Valencia, O. A., Qureshi, F., & Cheungpasitporn, W. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13121681 · Cited by 36
“The most commonly approved types of these devices are radiological image processing and computer-assisted triage and notification systems [6].”
BackgroundInfluentialEnsemble Deep Learning Model to Predict Lymphovascular Invasion in Gastric Cancer
Noh, M.-G., Lee, J., Cha, S., Kim, J., Kim, N., Kim, N., Gal, S. G. J., Choi, Y.-D., Kang, S.-R., Song, G., et al. (2024) · Cancers · doi:10.3390/cancers16020430 · Cited by 40
Machine learning applications in precision medicine: Overcoming challenges and unlocking potential
Nilius, H., Tsouka, S., Nagler, M., & Masoodi, M. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117872 · Cited by 44
Almarie, B., González-González, L. F., Barbosa, L. A. D. S., Lutz, A. M., Grosse, U., & Fregni, F. (2025) · Biomedicines · doi:10.3390/biomedicines13123005 · Cited by 41
Using AI–ML to Augment the Capabilities of Social Media for Telehealth and Remote Patient Monitoring
Leung, R. (2023) · Healthcare · doi:10.3390/healthcare11121704 · Cited by 45
Stogiannos, N., Gillan, C., Precht, H., dos Reis, C. S., Kumar, A., O’Regan, T., Ellis, V., Barnes, A., Meades, R., Pogose, M., et al. (2024) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2024.101717 · Cited by 35
McEntee, P. D., Singaravelu, A., McCarrick, C. A., Murphy, E., Boland, P. A., & Cahill, R. A. (2025) · Surgical Endoscopy · doi:10.1007/s00464-025-11621-8 · Cited by 37
Escalé-Besa, A., Vidal-Alaball, J., Miró Catalina, Q., Gracia, V. H. G., Marin-Gomez, F. X., & Fuster-Casanovas, A. (2024) · Healthcare · doi:10.3390/healthcare12121192 · Cited by 29
“At that time, the FDA listed 691 approved medical devices with artificial intelligence, of which 108 were approved in 2023 [31].”
BackgroundBiomarkers of Aging and Relevant Evaluation Techniques: A Comprehensive Review
Xue, T., Zhu, Z., Wang, L., Li, C., Sun, L., Wang, W., & Gong, W. (2023) · Aging and Disease · doi:10.14336/ad.2023.00808-1 · Cited by 62
Real-Time Jaundice Detection in Neonates Based on Machine Learning Models
Abdulrazzak, A. Y., Mohammed, S. L., Al‐Naji, A., & Chahl, J. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4010034 · Cited by 38
Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review
Stafford, H. D., Buell, J. B., Chiang, E., Ramesh, U. R., Migden, M. R., Nagarajan, P., Amit, M., & Yaniv, D. (2023) · Cancers · doi:10.3390/cancers15123094 · Cited by 34
Rimpi, Verma, S. J., Pinky, & Baldi, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03843-3 · Cited by 32
“To expedite the review process for innovative medical devices, the PMDA has established the Sakigake Designation System, which provides a faster approval pathway for technologies addressing urgent medical needs (Joshi et al. 2024).”
Review of Non-Invasive Imaging Technologies for Cutaneous Melanoma
Horton, L. A., Fakhoury, J. W., Manwar, R., Rajabi‐Estarabadi, A., Turk, D., O’Leary, S., Fotouhi, A., Daveluy, S. D., Jain, M., Nouri, K., et al. (2025) · Biosensors · doi:10.3390/bios15050297 · Cited by 28
Ethical and practical challenges of generative AI in healthcare and proposed solutions: a survey
Tung, T., Hasnaeen, S. M. N., & Zhao, X. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1692517 · Cited by 40
Exploring the role of ChatGPT in oncology: providing information and support for cancer patients
Cè, M., Chiarpenello, V., Bubba, A., Felisaz, P. F., Oliva, G., Irmici, G., & Cellina, M. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4020049 · Cited by 24
“The use of artificial intelligence in healthcare is not new, having already demonstrated surprising results in the high-performance analysis of biomedical data through machine learning and deep learning models [7].”
BackgroundRole of artificial intelligence in critical care nutrition support and research
Kittrell, H. D., Shaikh, A., Adintori, P. A., McCarthy, P. J., Kohli-Seth, R. D., Nadkarni, G. N., & Sakhuja, A. (2024) · Nutrition in Clinical Practice · doi:10.1002/ncp.11194 · Cited by 28
Smart Bioelectronics for Real-Time Diagnosis and Therapy of Body Organ Functions
Guo, L., Lee, H. K., Oh, S., Koirala, G. R., & Kim, T. (2025) · ACS Sensors · doi:10.1021/acssensors.5c00024 · Cited by 24
Wenderott, K., Krups, J., Weigl, M., & Wooldridge, A. R. (2025) · Journal of Medical Internet Research · doi:10.2196/63649 · Cited by 36
Bergomi, L., Nicora, G., Orlowska, M. A., Podrecca, C., Bellazzi, R., Fregosi, C., Salinaro, F., Bonzano, M., Crescenzi, G., Speciale, F., et al. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03045-0 · Cited by 33
“Today, AI technologies are reaching a level of maturity that allows them to be integrated into clinical practice, particularly in radiology, the area where most AI-powered medical devices have received Food and Drugs Administration (FDA) approval [1, 2].”
Applications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells
Isavand, P., Aghamiri, S. S., & Amin, R. (2024) · Biomedicines · doi:10.3390/biomedicines12081753 · Cited by 28
“[124,125].”
Artificial Intelligence for Clinical Management of Male Infertility, a Scoping Review
Naik, N. C., Roth, B. J., & Lundy, S. D. (2024) · Current Urology Reports · doi:10.1007/s11934-024-01239-z · Cited by 23
The role of AI in mitigating the impact of radiologist shortages: a systematised review
Achour, N., Zapata, T., Saleh, Y., Pierscionek, B. K., Muscat, N. A., Novillo-Ortiz, D., Morgan, C., & Chaouali, M. (2025) · Health and Technology · doi:10.1007/s12553-025-00970-y · Cited by 36
“The types of radiology AI systems are expanding and healthcare providers are looking to get formal approvals from agencies such as the Food and Drug Administration (FDA) and Conformité Européenne (CE) [27 ].”
Chettri, S. K., Deka, R. K., & Saikia, M. J. (2025) · AI · doi:10.3390/ai6010010 · Cited by 35
Artificial Intelligence in Asthma: Current Status, Opportunities, and Pitfalls
Gogali, A., Kyriakopoulos, C., Potonos, D., Ladias, A. A., Tatsis, K., & Κostikas, Κ. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.05.044 · Cited by 25
Multimodal integration strategies for clinical application in oncology
Zhang, B., Wan, Z., Luo, Y., Zhao, X., Samayoa, J. A., Zhao, W., & Wu, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1609079 · Cited by 36
The Chief Health AI Officer — An Emerging Role for an Emerging Technology
Beecy, A. N., Longhurst, C. A., Singh, K., Wachter, R. M., & Murray, S. G. (2024) · NEJM AI · doi:10.1056/aip2400109 · Cited by 20
Danielescu, C., Dabija, M. G., Nedelcu, A. H., Lupu, V. V., Lupu, A., Ioniuc, I. K., Gîlcă-Blanariu, G.-E., Donica, V. C., Anton, M.-L., & Mușat, O. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm14010045 · Cited by 24
Husain, A. N., Knake, L. A., Sullivan, B. A., Barry, J. S., Beam, K., Holmes, E., Hooven, T. A., McAdams, R. M., Moreira, A. G., Shalish, W., et al. (2024) · Pediatric Research · doi:10.1038/s41390-024-03774-4 · Cited by 24
Artificial General Intelligence for the Detection of Neurodegenerative Disorders
Qadri, Y. A., Ahmad, K., & Kim, S. W. (2024) · Sensors · doi:10.3390/s24206658 · Cited by 22
“The United States Food and Drug Administration (FDA) has approved several AI and machine learning (ML)-based radiological image analysis tools [14], therefore, AI and ML are coming to the forefront in the early detection and diagnosis of NDs. Neural networks (NNs) can accurately detect patterns in…”
BackgroundSingh, B., & Kaunert, C. (2024) · Engineering cyber-physical systems and critical infrastructures · doi:10.1007/978-3-031-65434-3_7 · Cited by 20
AI and omics technologies in biobanking: Applications and challenges for public health
Venturini, P., de Faria, P. L., & Cordeiro, J. V. (2025) · Public Health · doi:10.1016/j.puhe.2025.105726 · Cited by 23
Artificial Intelligence and Radiomics for Endometrial Cancer MRI: Exploring the Whats, Whys and Hows
Leo, E., Stanzione, A., Miele, M., Cuocolo, R., Sica, G., Scaglione, M., Camera, L., Maurea, S., & Mainenti, P. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010226 · Cited by 24
A Comprehensive Review of the Impact of Machine Learning and Omics on Rare Neurological Diseases
Alganmi, N. A. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4020073 · Cited by 23
“Radiomics, a novel omics field, involves high-throughput medical imaging assessments [23].”
BackgroundGenerative AI in Critical Care Nephrology: Applications and Future Prospects
Cheungpasitporn, W., Thongprayoon, C., Ronco, C., & KASHANI, K. B. (2024) · Blood Purification · doi:10.1159/000541168 · Cited by 23
“Understanding this framework is crucial for the responsible development and deployment of AI technologies in healthcare settings [35]: In the USA, the Food and Drug Administration (FDA) has taken a lead role in regulating AI and ML technologies in healthcare [36].”
Industry 6.0 capabilities in orthopaedics: Towards hyper-personalized and autonomous surgical care
Regmi, A., Jain, V., Baral, S., Jain, V. K., & Iyengar, K. P. (2025) · Journal of Orthopaedics · doi:10.1016/j.jor.2025.11.042 · Cited by 16
An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry
Georgiou, M. F., Nielsen, J., Chiriboga, R., & Kuker, R. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010117 · Cited by 15
“The predictive reliability and accuracy of such AI models are generally enhanced when they are trained and validated with diverse and comprehensive data sets [40].”
BackgroundEvaluating AI-based breastfeeding chatbots: quality, readability, and reliability analysis
Kacer, E. O. (2025) · PLOS ONE · doi:10.1371/journal.pone.0319782 · Cited by 14
“The Food and Drug Administration (FDA) has approved 521 medical AI models for some medical fields [32].”
van Breugel, M., Greenhawt, M., Eguíluz‐Gracia, I., Torres, M. J., Anagnostou, A., & Koppelman, G. H. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.08.022 · Cited by 22
Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives
Rossin, G., Zorzi, F., Ongaro, L., Piasentin, A., Vedovo, F., Liguori, G., Zucchi, A., Simonato, A., Bartoletti, R., Trombetta, C. S., et al. (2023) · BioMedInformatics · doi:10.3390/biomedinformatics3010008 · Cited by 15
Ong, W., Lee, A., Tan, W. C., Fong, K. T. D., Lai, D. D., Tan, Y. L., Low, X. Z., Ge, S., Makmur, A., Ong, S. J., et al. (2024) · Cancers · doi:10.3390/cancers16172988 · Cited by 21
Artificial Intelligence to Promote Racial and Ethnic Cardiovascular Health Equity
Amponsah, D., Thamman, R., Brandt, E. J., James, C. A., Spector‐Bagdady, K., & Yong, C. M. (2024) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-024-00745-6 · Cited by 17
“Presently, the FDA has approved more than 600 AI/ ML-enabled medical devices, spanning various applications such as radiological image processing/identification software and computer-assisted triage/ notification software [20].”
A Review of Neuro-ML Breakthroughs in Addressing Neurological Disorders
Roșca, C.-M., & Stancu, A. (2025) · Applied Sciences · doi:10.3390/app15105442 · Cited by 17
Lee, B., Patel, S., Favorito, C., Sandri, S., Jennings, M. R., & Dai, T. (2025) · NEJM AI · doi:10.1056/aira2500061 · Cited by 20
Gilvaz, V. J., Sudheer, A., & Reginato, A. M. (2025) · Current Rheumatology Reports · doi:10.1007/s11926-025-01193-w · Cited by 15
Artificial intelligence and higher education: A systematic review
Behera, A., Trivedi, P., Patra, S., & Makeni, C. (2025) · American Journal of STEM Education · doi:10.32674/0x43s107 · Cited by 20
Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics
Horton, S., Wilson, M. L., Cheung, A., DeStigter, K. K., Kohli, M., Sayed, S., Schroeder, L. F., Sullivan, R. J., Tan, B.-S., Alooh, M., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00804-9 · Cited by 15
Artificial Intelligence in Healthcare: 2023 Year in ReviewPreprint
Awasthi, R., Mishra, S. V., Grasfield, R. H., Maslinski, J., Mahapatra, D., Cywiński, J. B., Khanna, A. K., Maheshwari, K. K., Dave, C., Khare, A., et al. (2024) · medRxiv · doi:10.1101/2024.02.28.24303482 · Cited by 25
“The research is not only related to trials exploring opportunities to apply AI in healthcare, but also related to "mature” real world testing and deployment of FDA approved AI solutions in healthcare[2,3].”
A review of image processing and analysis of computed tomography images using deep learning methods
Anderson, D., Ramachandran, P., Trapp, J., & Fielding, A. L. (2025) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-025-01635-w · Cited by 16
Machine learning in cancer imaging for enhanced precision in diagnosis and therapy
Chow, J. C. L. (2026) · Discover Computing · doi:10.1007/s10791-026-10078-0 · Cited by 17
“Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have set guidelines for AI-based medical devices [116].”
Zhu, Z. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107809 · Cited by 16
AI in plastic surgery: customizing care for each patient
Brenac, C., Fazilat, A. Z., Fallah, M., Kawamoto-Duran, D., Sunwoo, P. S., Longaker, M. T., Wan, D. C., & Guo, J. L. (2024) · Artificial Intelligence Surgery · doi:10.20517/ais.2024.49 · Cited by 15
Kakish, D. R. K., AlSamhori, J. F., Fajardo, A. N. R., Qaqish, L. N., Jaber, L. A., Abujudeh, R., Al-Zuriqat, M., Mohammed, A. Y., & Nashwan, A. J. (2025) · Dermatological Reviews · doi:10.1002/der2.70018 · Cited by 20
“Aligning these evolving international standards will be crucial to balance innovation with equity in derma-topathology applications [69, 70, 75].”
Advances in Artificial Intelligence-Based Medical Devices for Healthcare Applications
Tettey, F., Parupelli, S. K., Bauer, S. R., Bhattarai, N., & Desai, S. S. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00379-1 · Cited by 28
Segun-Omosehin, O., Omiye, J. A., Elalfy, A., Sheriff, S. M., Kuti, F., Omole, O., Ogunyankin, K. O., Idemili-Aronu, N., Olawepo, J. O., Ezeanolue, E. E., et al. (2025) · npj Cardiovascular Health · doi:10.1038/s44325-025-00055-9 · Cited by 17
Post-deployment Monitoring of AI Performance in Intracranial Hemorrhage Detection by ChatGPT
ROHREN, E. M., Ahmadzade, M., Colella, S., Kottler, N. E., Krishnan, S., Poff, J. A., Rastogi, N., Wiggins, W. F., Yee, J., Zuluaga, C., et al. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.07.055 · Cited by 14
Santhiya, P., Bharathi, M. N., Menon, R. R., Rajalakshmi, K., & Manikandan, J. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100132 · Cited by 16
New Era of Intelligent Medicine: Future Scope and Challenges
Kumar, A., Gupta, A., & Raj, U. (2024) · International Conference on Reliability, Infocom Technologies and Optimization (Trends and Future Directions) (ICRITO) · doi:10.1109/icrito61523.2024.10522148 · Cited by 11
“The key players in market with the maximum number of FDA approved AI based medical devices are GE Healthcare (58 devices in 2023) and Siemens (40 devices in 2023) [13], [14], [15].”
BackgroundHow Should Medicare Pay for Artificial Intelligence?
Zink, A., Chernew, M. E., & Neprash, H. T. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.1648 · Cited by 15
Metadata
- Authors
- Joshi, G., Jain, A., Araveeti, S. R., Adhikari, S., Garg, H., & Bhandari, M.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- New England College (US)
- Texas A&M University (US)
- Corresponding author
- Bhandari, Mukund
- Venue
- Electronics
- Publisher
- MDPI AG
- Published
- 2024-01-24
- Volume
- 13
- Issue
- 3
- Pages
- 498
- ISSN
- 2079-9292 (ISSN-L)
- OpenAlex
- W4391221083
- Cited by
- 294
- References
- 18
- Citations by year
- 2026: 75 · 2025: 110 · 2024: 88
- FWCI
- 25.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Electronics (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
- Physical Sciences › Computer Science › Information Systems › Internet of Things and AI
- Keywords
- FDA device approval, 510(k) clearance, substantial equivalence, medical device regulation, radiology, diversity in clinical trials, medical device recall
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.